Confirm whether your organization is eligible for controlled pilot access.
Best-fit pilots use public, synthetic, or de-identified genomic cases and evaluate review package usefulness under human review.
Qualification checklist
- Lab or scientific team can evaluate public/synthetic/de-identified cases.
- No PHI or raw patient identifiers are submitted during controlled pilot.
- Team understands Tynixa does not provide final diagnosis or final ACMG.
- Reviewers can provide structured feedback on review package usefulness.
- Pilot scope, timeline, and commercial decision path can be defined.
Recommended next step
After payment or pilot request, complete qualification and schedule a pilot briefing. Internal operators can record qualification through /api/p247/onboarding/qualification.